Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
Vukotic R, Conti F, Fagiuoli S, Morelli MC, Pasulo L, Colpani M, Foschi FG, Berardi S, Pianta P, Mangano M, Donato MF, Malinverno F, Monico S, Tamè M, Mazzella G, Belli LS, Viganò R, Carrai P, Burra P, Russo FP, Lenci I, Toniutto P, Merli M, Loiacono L, Iemmolo R, Degli Antoni AM, Romano A, Picciotto A, Rendina M, Andreone P; AISF-SOFOLT Study group. Vukotic R, et al. Among authors: toniutto p. J Viral Hepat. 2017 Oct;24(10):858-864. doi: 10.1111/jvh.12712. Epub 2017 May 5. J Viral Hepat. 2017. PMID: 28370880
Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U, Adani GL, Bragantini F, Londero A, Comuzzi C, Rossetto A, Lorenzin D, Bresadola V, Risaliti A, Pea F, Toniutto P, Donini A, De Anna D, Bresadola F, Tavio M, Viale P. Baccarani U, et al. Among authors: toniutto p. Transplant Proc. 2011 May;43(4):1119-22. doi: 10.1016/j.transproceed.2011.01.124. Transplant Proc. 2011. PMID: 21620067
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group. Avolio AW, et al. Am J Transplant. 2011 Dec;11(12):2724-36. doi: 10.1111/j.1600-6143.2011.03732.x. Epub 2011 Sep 15. Am J Transplant. 2011. PMID: 21920017 Free article.
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.
Giannelli V, Giusto M, Farcomeni A, Ponziani FR, Pompili M, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, De Martin E, Miglioresi L, Di Paolo D, Fagiuoli S, Merli M; AISF RECOLT-C group study. Giannelli V, et al. Among authors: toniutto p. Transpl Int. 2012 Apr;25(4):448-54. doi: 10.1111/j.1432-2277.2012.01440.x. Epub 2012 Feb 21. Transpl Int. 2012. PMID: 22353419 Free article.
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study.
Ponziani FR, Milani A, Gasbarrini A, Zaccaria R, Viganò R, Donato MF, Morelli MC, Miglioresi L, Pasulo L, Rendina M, Paolo DD, Marino M, Toniutto P, Fagiuoli S, Pompili M. Ponziani FR, et al. Among authors: toniutto p. Ann Hepatol. 2012 May-Jun;11(3):338-42. Ann Hepatol. 2012. PMID: 22481452 Free article.
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P. Bitetto D, et al. Among authors: toniutto p. Transplantation. 2012 May 27;93(10):1038-44. doi: 10.1097/TP.0b013e31824df7f3. Transplantation. 2012. PMID: 22495472
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group. Lampertico P, et al. Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2. Gut. 2013. PMID: 22859496 Clinical Trial.
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers.
Ponziani FR, Milani A, Gasbarrini A, Zaccaria R, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Cescon M, Burra P, Miglioresi L, Merli M, Paolo DD, Fagiuoli S, Pompili M; AISF RECOLT-C Group. Ponziani FR, et al. Among authors: toniutto p. Transpl Int. 2013 Mar;26(3):281-9. doi: 10.1111/tri.12027. Epub 2012 Dec 11. Transpl Int. 2013. PMID: 23230956 Free article.
233 results